Pfizer PFE is one of the largest and most successful drugmakers in oncology with an established presence in breast, ...

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...

Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

Pfizer agreed on Thursday to acquire Hospira, a provider of injectable drugs and biosimilars, for about $17bn in it's first big deal since it failed to buy AstraZeneca last year. The New York-based ...

“Tamil Nadu has become a preferred destination for global pharma leaders like Pfizer, Roche, and AstraZeneca to establish their GCCs and innovation hubs. This achievement is a testament to our ...

Pharmaceutical giant Pfizer has been circling its smaller rival for months. AstraZeneca has rejected every offer saying Pfizer undervalues the... Pfizer Drops $119 Billion Bid For AstraZeneca It would ...

AstraZeneca will sell discounted drugs on TrumpRx, aligning with the MFN executive order to avoid potential tariffs. The agreement includes a $50 billion investment in US drug manufacturing and R&D, ...

Sales of Pfizer’s PFE COVID products, Comirnaty and Paxlovid, declined from their peak with the end of the pandemic. Their ...